Jane Street Group, LLC Cytek Biosciences, Inc. Transaction History
Jane Street Group, LLC
- $444 Billion
- Q4 2024
A detailed history of Jane Street Group, LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 67,197 shares of CTKB stock, worth $344,048. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,197
Previous 136,402
50.74%
Holding current value
$344,048
Previous $755,000
42.25%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CTKB
# of Institutions
150Shares Held
74MCall Options Held
1KPut Options Held
0-
Black Rock Inc. New York, NY17.1MShares$87.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$60 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD8.25MShares$42.2 Million1.27% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$34.1 Million1.65% of portfolio
-
State Street Corp Boston, MA4.51MShares$23.1 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $689M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...